Company intelligence / Profile preview
TicTwo Therapeutics Inc.
Wilmington, Delaware, USAtictwotherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TicTwo Therapeutics Inc. is a newly established biotechnology/pharmaceutical company incorporated in Delaware on February 29, 2024. It was created as a subsidiary of Alembic Global Holding SA, which itself is wholly owned by Alembic Pharmaceuticals Limited. The company has not yet publicly disclosed any products, pipeline programs, or clinical results[1][5].
- Therapeutic areas
- Other
- Modalities
- Not specified in available sources (likely early-stage, modalities not yet disclosed)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on TicTwo Therapeutics Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TicTwo Therapeutics Inc..